help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on March 30, 2006, doi:10.1164/rccm.200509-1461OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online Supplement
Right arrow All Versions of this Article:
200509-1461OCv1
174/1/31    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Berenson, C. S.
Right arrow Articles by Sethi, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Berenson, C. S.
Right arrow Articles by Sethi, S.
American Journal of Respiratory and Critical Care Medicine Vol 174. pp. 31-40, (2006)
© 2006 American Thoracic Society
doi: 10.1164/rccm.200509-1461OC


Original Article

Impaired Alveolar Macrophage Response to Haemophilus Antigens in Chronic Obstructive Lung Disease

Charles S. Berenson, Catherine T. Wrona, Lori J. Grove, Jane Maloney, Mary Alice Garlipp, Paul K. Wallace, Carleton C. Stewart and Sanjay Sethi

Infectious Disease Division, Department of Veterans Affairs Western New York Healthcare System, State University of New York at Buffalo School of Medicine; and Laboratory of Flow Cytometry, Roswell Park Cancer Institute, Buffalo, New York

Correspondence and requests for reprints should be addressed to Charles S. Berenson, Division of Infectious Diseases (151), VA Western NY Healthcare System, 3495 Bailey Avenue, Buffalo, NY 14215. E-mail: berenson{at}acsu.buffalo.edu

Rationale: Interactions of nontypeable Haemophilus influenzae (NTHI) with macrophages are implicated in the pathogenesis of chronic obstructive pulmonary disease (COPD). However, the immunologic mechanisms that mediate NTHI-macrophage inflammation are poorly understood. Outer membrane protein (OMP) P6 and lipooligosaccharide (LOS) of NTHI are potent immunomodulators. We theorized that alveolar macrophages in COPD possess fundamental immune defects that permit NTHI to evade host responses.

Objective: To test this hypothesis, we obtained human alveolar and blood macrophages from exsmokers with COPD, exsmokers without COPD, and nonsmokers.

Methods: Alveolar and blood macrophages from each donor were incubated with purified LOS and OMP P6 and with OMP P2 and the total outer membrane preparation (0.1–1 µg/ml).

Measurements: Supernatants (24 h) were assayed for IL-1beta, TNF-{alpha}, IL-10, IL-12, and IL-8 by multianalyte multiplexed flow cytometry.

Results: Comparative induction of COPD and non-COPD alveolar macrophages by LOS and OMP P6 revealed diminished IL-8, TNF-{alpha}, and IL-1beta responses of COPD alveolar macrophages (p <= 0.03 for each). COPD alveolar macrophages also had diminished responses to total outer membrane (p <= 0.03 for each). In contrast, COPD blood macrophages had no significant differences among donor groups in IL-8, TNF-{alpha}, or IL-1beta responsiveness to NTHI antigens. Diminished IL-12 responses of COPD blood macrophages to NTHI antigens, compared with nonsmokers, could not be independently dissociated from group differences in age and pack-years.

Conclusions: These findings support a paradigm of defective immune responsiveness of alveolar macrophages, but not blood macrophages, in COPD.

Key Words: chronic obstructive pulmonary disease • macrophage, alveolar • nontypeable Haemophilus influenzae • phagocytosis




This article has been cited by other articles:


Home page
Proc Am Thorac SocHome page
S. Sethi, P. Mallia, and S. L. Johnston
New Paradigms in the Pathogenesis of Chronic Obstructive Pulmonary Disease II
Proceedings of the ATS, September 15, 2009; 6(6): 532 - 534.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
G. J. Gaschler, M. Skrtic, C. C. J. Zavitz, M. Lindahl, P.-O. Onnervik, T. F. Murphy, S. Sethi, and M. R. Stampfli
Bacteria Challenge in Smoke-exposed Mice Exacerbates Inflammation and Skews the Inflammatory Profile
Am. J. Respir. Crit. Care Med., April 15, 2009; 179(8): 666 - 675.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
S. Sethi and T. F. Murphy
Infection in the Pathogenesis and Course of Chronic Obstructive Pulmonary Disease
N. Engl. J. Med., November 27, 2008; 359(22): 2355 - 2365.
[Full Text] [PDF]


Home page
Ther Adv Respir DisHome page
F. Pasqua, G. Biscione, G. Crigna, and M. Cazzola
Prulifloxacin in the treatment of acute exacerbations of COPD in cigarette smokers
Therapeutic Advances in Respiratory Disease, August 1, 2008; 2(4): 209 - 214.
[Abstract] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
G. J. Gaschler, C. C. J. Zavitz, C. M. T. Bauer, M. Skrtic, M. Lindahl, C. S. Robbins, B. Chen, and M. R. Stampfli
Cigarette Smoke Exposure Attenuates Cytokine Production by Mouse Alveolar Macrophages
Am. J. Respir. Cell Mol. Biol., February 1, 2008; 38(2): 218 - 226.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2006 American Thoracic Society
  ATS 2008 State of the Art Course